Search results (61)
« Back to NewsThe latest news, stories and exciting findings from across the Oxford cancer research community
Blood proteins may be able to predict risk of cancer more than seven years before it is diagnosed
15 May 2024
Proteins linked to cancer can start appearing in people’s blood more than seven years before they’re diagnosed. In the future, it’s possible doctors could use these early warning signs to find and treat cancer much earlier than they’re able to today.
OCION Funding Scheme: In conversation with David Church and Luciana Gneo
10 May 2024
The mission of the Oxford Cancer Immuno-Oncology Network (OCION) Funding Scheme is to pump-prime innovative Oxford-based immuno-oncology research and build capacity in cancer immunology. We sat down with 2023 awardees, David Church and Luciana Gneo, to discuss what research the fund will enable them to carry out.
Researchers develop new way to identify people with new-onset diabetes who are at risk of pancreatic cancer
8 May 2024
The new method could help people with new-onset diabetes at high-risk of developing pancreatic cancer to be identified more accurately so that they can be monitored.
Population-scale digital capabilities can protect cancer patients at risk of COVID
25 July 2023
Research led by the Nuffield Department of Medicine has been published in Nature Scientific Reports, investing the effect of COVID-19 across the cancer population over the course of the pandemic. This analysis is the world’s largest and most comprehensive cancer evaluation showcasing the United Kingdom’s digital capabilities and the potential of population-scale cancer studies.
Research confirms important differences in colorectal cancer patients with a history of Inflammatory Bowel Disease
12 December 2022
IBD-associated colorectal cancers were found to occur in younger patients and have worse outcomes. Researchers call for urgent improvement of early detection methods to provide more risk-based and personalised care.
Jan Bornschein receives MRC Clinical Academic Research Partnership (CARP) Award
8 December 2022
Dr Bornschein will join the Simmons Group for a project developing strategies to identify patients at high risk of gastritis/gastric cancer.
Unique Clinical Imaging Dataset Released for Artificial Intelligence Research to Accelerate Diagnosis of Prostate Cancer
23 September 2022
The National Cancer Imaging Translational Accelerator (NCITA) in partnership with the ReIMAGINE Consortium have announced the release of a unique clinical imaging dataset from the Prostate MRI Imaging Study (PROMIS)).
Measured weight loss associates with an increased risk of a cancer diagnosis
4 August 2022
Weight loss is a sign of undiagnosed cancer regardless of the interval over which it occurs.
Comparing polygenic risk scores for risk prediction in individuals
3 August 2022
Substantial disagreement in individual risk prediction was found between different polygenic risk scores for breast cancer, hypertension and dementia using genotyping data from the UK Biobank.
Time-varying nature of clinical risk factors for pancreatic cancer may aid earlier diagnosis
28 June 2022
Body mass index, blood tests, comorbidities and medication use are temporally associated with cancer risk in the three years before a pancreatic cancer diagnosis.
Early detection innovation award for Oxford researchers
17 May 2022
Professor Julia Hippisley-Cox and Dr Tingting Zhu win funding for their collaborative project on novel test technologies for patient triage in primary care.
Dairy products linked to increased risk of cancer
6 May 2022
The first major study to investigate dairy consumption and cancer risk in Chinese adults found that greater intake was associated with higher risks of liver cancer and female breast cancer.
Blood tests provide no additional information to FIT alone when prioritising patients for colorectal cancer referral
15 March 2022
Faecal immunochemical testing (FIT) alone leads to the identification of the same number of patients with colorectal cancer as more complicated approaches that combine the FIT result with the results of commonly used blood tests.
Adiposity in early life, but not adulthood, may protect against breast cancer
8 March 2022
New data from the Million Women Study indicates that adiposity at different life stages is likely to affect the risk of postmenopausal breast cancer through distinct mechanisms.
New study finds lower risks of cancer for vegetarians, pescatarians and low meat-eaters
24 February 2022
Results from a large-scale analysis show that following a vegetarian or pescatarian (fish-eating) diet could significantly reduce the risk of developing cancer – but even limiting red and processed meat to five meals a week or less may also have a benefit.
First major UK prospective study for liver cancer underway
24 February 2022
The Pearl clinical study will recruit 3000 patients with high-risk conditions for liver cancer with the aim of detecting liver cancer earlier as part of the Cancer Research UK-funded DeLIVER programme.
How Oxford has shaped cancer science
4 February 2022
As part of World Cancer Day 2022 we are diving into 10 of Oxford’s most impactful historical and modern contributions to the field of cancer science and treatment. Read more about what Oxford researchers have done to shape this ever-important area of medical science.
Toral Gathani awarded Professorship for work into ethnicity and breast cancer
1 February 2022
Toral Gathani has been awarded a prestigious Hunterian Professorship (2022) by the Royal College of Surgeons of England. The award recognises her work on ethnicity and breast cancer.
Groundbreaking Oxford research could lead to early diagnosis of pancreatic cancer
27 January 2022
New research into the onset of diabetes which could go on to help in the early diagnosis of pancreatic cancer is being led by scientists at the University of Oxford.
Identifying protein biomarkers for pancreatic cancer
26 January 2022
Dr Christiana Kartsonaki and colleagues from the China Kadoorie Biobank have identified several proteins in the blood that are associated with an increased risk of pancreatic cancer.